Drug Profile
Research programme: cathepsin S/K inhibitors - Grunenthal
Alternative Names: Inflammation – Cathepsin S/K - GrunenthalLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Grunenthal
- Class
- Mechanism of Action Cathepsin K inhibitors; Cathepsin S inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in Germany
- 19 Apr 2013 Early research in Inflammation in Germany (unspecified route)